Aims to reduce amputations and improve recovery outcomes for high-risk patientsHYDERABAD, India, May 5, 2026 /PRNewswire/ -- Reinforcing its commitment to…
NEW YORK, April 04, 2026 (GLOBE NEWSWIRE) -- As research continues to reveal the critical relationship between vitamin D3 and…
∇ This medicine is subject to additional monitoring. This will allow quick identification of new safety information.LONDON, Dec. 2, 2025 /PRNewswire/…
Abbott's denosumab biosimilar is the first approved in Thailand, making advanced therapy for osteoporosis and cancer-related bone loss more affordable for…